Biotech Values

[DewDiligence]

Does anyone feel if one of the two drugs that make-up Qnexa wasn't generic the advisory panel would have voted differently?

If Qnexa were a novel drug, I think the panel’s sentiment would have been considerably different and might well have produced a plurality of negative votes.